$MATN Oncotelic Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Oncotelic Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Oncotelic Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Oncotelic Therapeutics, Inc. for free.
CIK Number: 0000908259
IRS Number: 133679168
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: MATN
Company Address: 29397 AGOURA RD. #107 AGUORA HILLS 91301
Phone number: 650-635-7000
Former name: OXIGENE INC, date of change: 1993-06-28
Former name: MATEON THERAPEUTICS INC, date of change: 2016-06-13
Prev close: $0.70
Average Daily Volume: 519,686
Days Low: $0.00
Year Low: $0.49
Year High: $1.55
Oncotelic Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 24 2020 | MATN | MATEON THERAPEUTIC ... | Shah Amit B. | CHIEF FINANCIAL OFF ... | Buy | P | 0.19 | 8,220 | 1,562 | 60,000 | 51.8 K to 60 K (+15.87 %) |
Nov 24 2020 | MATN | MATEON THERAPEUTIC ... | Shah Amit B. | CHIEF FINANCIAL OFF ... | Buy | P | 0.19 | 20,088 | 3,817 | 51,780 | 31.7 K to 51.8 K (+63.39 %) |
Nov 24 2020 | MATN | MATEON THERAPEUTIC ... | Shah Amit B. | CHIEF FINANCIAL OFF ... | Buy | P | 0.20 | 31,692 | 6,180 | 31,692 | 0 to 31.7 K |
Mar 27 2020 | MATN | MATEON THERAPEUTIC ... | Trieu Vuong | CHIEF EXECUTIVE OFF ... | Buy | P | 0.12 | 3,000 | 360 | 15,761,808 | 15.8 M to 15.8 M (+0.02 %) |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | Schwieterman William D | President and CEO | Option Exercise | A | 0.22 | 500,000 | 110,000 | 500,000 | |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | Schwieterman William D | President and CEO | Option Exercise | A | 0.22 | 500,000 | 110,000 | 500,000 | |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | SANDAGE BOBBY W. JR., PHD. | Director | Option Exercise | A | 0.22 | 258,171 | 56,798 | 258,171 | |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | Reynolds Donald Rogers | Director | Option Exercise | A | 0.22 | 258,171 | 56,798 | 258,171 | |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | Pedder Simon | Director | Option Exercise | A | 0.22 | 258,171 | 56,798 | 258,171 | |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | A | 0.22 | 500,000 | 110,000 | 500,000 | |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | A | 0.22 | 250,000 | 55,000 | 250,000 | |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | CHAPLIN DAVID | Director | Option Exercise | A | 0.22 | 258,171 | 56,798 | 258,171 | |
Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | Reynolds Donald Rogers | Director | Option Exercise | P | 0.40 | 125,000 | 50,000 | 125,000 | |
Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | Reynolds Donald Rogers | Director | Option Exercise | P | 0.40 | 125,000 | 50,000 | 125,000 | |
Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | Reynolds Donald Rogers | Director | Buy | P | 0.00 | 250,000 | 0 | 280,000 | 30 K to 280 K (+833.33 %) |